The Effect of a Dominant Inhibitory p53 Protein on Stress Responses Induced by Toxic and Non-Toxic Concentrations of Anisomycin in PC12 Cells

Anisomycin, a ribotoxic compound, is an efficient inhibitor of eukaryotic translation: at toxic concentrations, it interferes with the function of ribosomal peptidyl transferase, blocks protein synthesis, and ultimately leads to apoptosis. The process is accompanied by the activation of various cellular stress mechanisms. Subinhibitory anysomycin concentrations, in contrast, do not inhibit translation and cause apoptosis, but still activate certain stress pathways. The present study aimed to compare the signaling effects of toxic (1 µg/mL) and non-toxic (10 ng/mL) anisomycin treatment in PC12 cells. In addition, the role of the p53 tumor suppressor protein in these processes was explored, using a PC12 cell line expressing a dominant inhibitory p53 protein. Apoptosis-mediating events (PKR cleavage; eIF2α phosphorylation; activation of caspase 3, 8, and 9 enzymes) were caused by high, but not low, anisomycin concentration in a p53-dependent manner. MAPK pathways (JNK, p38 MAPK, ERK) were stimulated by non-toxic anisomycin treatment, with a more complex p53 involvement. The apoptotic response of cells appeared to be supported by exosomal paracrine signaling.

Authors

Institutions

Publication Details

Journal
Biology
Published
2025-11-21
DOI
https://doi.org/10.3390/biology14121634
Primary Topic
Cancer-related Molecular Pathways
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The Effect of a Dominant Inhibitory p53 Protein on Stress Responses Induced by Toxic and Non-Toxic Concentrations of Anisomycin in PC12 Cells

Marianna Pap, Zita Árvai, Renáta Schipp, Judit Bátor et al.
Biology
Cancer-related Molecular Pathways
article

The Effect of a Dominant Inhibitory p53 Protein on Stress Responses Induced by Toxic and Non-Toxic Concentrations of Anisomycin in PC12 Cells

Marianna Pap, Zita Árvai, Renáta Schipp, Judit Bátor, Judit Varga, Mónika Vecsernyés, József Szeberényi, Petra Kele-Morvai
article en

Abstract

Anisomycin, a ribotoxic compound, is an efficient inhibitor of eukaryotic translation: at toxic concentrations, it interferes with the function of ribosomal peptidyl transferase, blocks protein synthesis, and ultimately leads to apoptosis. The process is accompanied by the activation of various cellular stress mechanisms. Subinhibitory anysomycin concentrations, in contrast, do not inhibit translation and cause apoptosis, but still activate certain stress pathways. The present study aimed to compare the signaling effects of toxic (1 µg/mL) and non-toxic (10 ng/mL) anisomycin treatment in PC12 cells. In addition, the role of the p53 tumor suppressor protein in these processes was explored, using a PC12 cell line expressing a dominant inhibitory p53 protein. Apoptosis-mediating events (PKR cleavage; eIF2α phosphorylation; activation of caspase 3, 8, and 9 enzymes) were caused by high, but not low, anisomycin concentration in a p53-dependent manner. MAPK pathways (JNK, p38 MAPK, ERK) were stimulated by non-toxic anisomycin treatment, with a more complex p53 involvement. The apoptotic response of cells appeared to be supported by exosomal paracrine signaling.

BiologyVol. 14(12)
University of Pecs (HU)
Openalex Percentile: Top 51%
Cancer-related Molecular Pathways
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.